CRSP EBITDA Margin
Crispr Therapeutics Ag · EBITDA Margin
CRSP EBITDA Margin
Latest reported-3390.20%period ending
CRSP EBITDA Margin (0.00% → -3390.20%)
Annual ebitda margin
High-resolution chart · PNG
CRSP ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -15,911.2821% | |
| -981.16% | |
| -35.3743% | |
| -143,653.211% | |
| 43.5322% | |
| -48,018.2197% | |
| 17.7717% | |
| -4,975.1601% | |
| -150.3134% | |
| -266.1309% | |
| -10,358.7045% | |
| 0% |